Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 183

1.

Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study.

Bartoloni E, Gonzalez-Gay MA, Scirè C, Castaneda S, Gerli R, Lopez-Longo FJ, Martinez-Barrio J, Govoni M, Furini F, Pina T, Iannone F, Giannini M, Nuño L, Quartuccio L, Ortego-Centeno N, Alunno A, Specker C, Montecucco C, Triantafyllias K, Balduzzi S, Sifuentes-Giraldo WA, Paolazzi G, Bravi E, Schwarting A, Pellerito R, Russo A, Selmi C, Saketkoo LA, Fusaro E, Parisi S, Pipitone N, Franceschini F, Cavazzana I, Neri R, Barsotti S, Codullo V, Cavagna L.

Autoimmun Rev. 2017 Jan 29. pii: S1568-9972(17)30020-4. doi: 10.1016/j.autrev.2017.01.008. [Epub ahead of print] Review.

PMID:
28147261
2.

Robot-assisted laparoscopic gastrectomy for gastric cancer.

Caruso S, Franceschini F, Patriti A, Roviello F, Annecchiarico M, Ceccarelli G, Coratti A.

World J Gastrointest Endosc. 2017 Jan 16;9(1):1-11. doi: 10.4253/wjge.v9.i1.1. Review.

3.

The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus.

Taraborelli M, Lazzaroni MG, Martinazzi N, Fredi M, Cavazzana I, Franceschini F, Tincani A.

Reumatismo. 2016 Dec 16;68(3):137-143. doi: 10.4081/reumatismo.2016.891.

4.

Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options.

Fredi M, Bartoli F, Cavazzana I, Ceribelli A, Carabellese N, Tincani A, Satoh M, Franceschini F.

Clin Exp Rheumatol. 2016 Nov 14. [Epub ahead of print]

PMID:
27908312
5.

Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.

Ceribelli A, Isailovic N, De Santis M, Generali E, Fredi M, Cavazzana I, Franceschini F, Cantarini L, Satoh M, Selmi C.

Clin Rheumatol. 2017 Feb;36(2):469-475. doi: 10.1007/s10067-016-3453-0.

PMID:
27761751
6.

Antibodies against antigens related to Scleroderma in a cohort of patients with Morphea.

Arisi M, Cavazzana I, Cerutti ME, Ferrari F, Carabellese N, Rossi MT, Tincani A, Calzavara-Pinton PG, Franceschini F.

G Ital Dermatol Venereol. 2016 Oct 5. [Epub ahead of print]

PMID:
27706114
7.

Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.

Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M.

Autoimmun Rev. 2016 Oct;15(10):983-93. doi: 10.1016/j.autrev.2016.07.023. Review.

PMID:
27491568
8.

Laparoscopic and robot-assisted gastrectomy for gastric cancer: Current considerations.

Caruso S, Patriti A, Roviello F, De Franco L, Franceschini F, Coratti A, Ceccarelli G.

World J Gastroenterol. 2016 Jul 7;22(25):5694-717. doi: 10.3748/wjg.v22.i25.5694. Review.

9.

Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus.

Iaccarino L, Bettio S, Reggia R, Zen M, Frassi M, Andreoli L, Gatto M, Piantoni S, Nalotto L, Franceschini F, Larosa M, Fredi M, Punzi L, Tincani A, Doria A.

Arthritis Care Res (Hoboken). 2017 Jan;69(1):115-123. doi: 10.1002/acr.22971.

PMID:
27390293
10.

Left ventricular function in rheumatoid arthritis during anti-TNF-α treatment: a speckle tracking prospective echocardiographic study.

Vizzardi E, Cavazzana I, Franceschini F, Bonadei I, Sciatti E, Lombardi CM, Tincani A, Metra M.

Monaldi Arch Chest Dis. 2016 Jun 22;84(1-2):716. doi: 10.4081/monaldi.2015.716.

11.

The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus.

Taraborelli M, Leuenberger L, Lazzaroni MG, Martinazzi N, Zhang W, Franceschini F, Salmon J, Tincani A, Erkan D.

Lupus. 2016 Oct;25(12):1365-8. doi: 10.1177/0961203316637431.

PMID:
26945023
12.

Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera.

Cavazzana I, Fredi M, Ceribelli A, Mordenti C, Ferrari F, Carabellese N, Tincani A, Satoh M, Franceschini F.

J Immunol Methods. 2016 Jun;433:1-5. doi: 10.1016/j.jim.2016.02.017.

PMID:
26906088
13.

Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.

Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castañeda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Pina Murcia T, La Corte R, Furini F, Foschi V, Bachiller Corral J, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bogliolo L, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Salaffi F, Montecucco C, González-Gay MA; AENEAS (American and European NEtwork of Antisynthetase Syndrome) Collaborative Group..

Clin Rev Allergy Immunol. 2017 Feb;52(1):71-80. doi: 10.1007/s12016-016-8528-9. Review.

PMID:
26782036
14.

Prognostic value of diastolic dysfunction in asymptomatic rheumatoid arthritis patients without cardiovascular risk factors.

Vizzardi E, Bazzani C, Cavazzana I, Sciatti E, Bonadei I, Franceschini F, Tincani A, Metra M.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2):352. No abstract available.

PMID:
26632765
15.

The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.

Cavazzana I, Fredi M, Selmi C, Tincani A, Franceschini F.

Clin Rev Allergy Immunol. 2017 Feb;52(1):88-98. doi: 10.1007/s12016-015-8517-4. Review.

PMID:
26514357
16.

Dr. Reggia, et al, reply.

Reggia R, Tincani A, Franceschini F, Cavazzana I.

J Rheumatol. 2015 Oct;42(10):1995. doi: 10.3899/jrheum.150688. No abstract available.

PMID:
26429209
17.

Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients.

Codullo V, Cereda E, Klersy C, Cavazzana I, Alpini C, Bonardi C, Turri A, Franceschini F, Caccialanza R, Montecucco C, Caporali R.

Rheumatology (Oxford). 2016 Feb;55(2):315-9. doi: 10.1093/rheumatology/kev322.

PMID:
26359329
18.

Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.

Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castañeda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Murcia TP, La Corte R, Furini F, Foschi V, Corral JB, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Montecucco C, González-Gay MA; AENEAS (American, European NEtwork of Antisynthetase Syndrome) collaborative group..

Medicine (Baltimore). 2015 Aug;94(32):e1144. doi: 10.1097/MD.0000000000001144.

19.

Myositis autoantibodies and clinical phenotypes.

Ghirardello A, Borella E, Beggio M, Franceschini F, Fredi M, Doria A.

Auto Immun Highlights. 2014 Aug 23;5(3):69-75. doi: 10.1007/s13317-014-0060-4. Review.

20.

Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference.

Bonanni A, Vaglio A, Bruschi M, Sinico RA, Cavagna L, Moroni G, Franceschini F, Allegri L, Pratesi F, Migliorini P, Candiano G, Pesce G, Ravelli A, Puppo F, Martini A, Tincani A, Ghiggeri GM.

Autoimmun Rev. 2015 Aug;14(8):692-702. doi: 10.1016/j.autrev.2015.04.004. Review.

PMID:
25888464
Items per page

Supplemental Content

Loading ...
Support Center